Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WAKE-UP: MRI-based Thrombolysis in Wake-up Stroke
NCT01525290Phase 3Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Sep 2012
- Primary completion
- Oct 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Alteplase with Placebo (2 arms). Primary endpoints: Efficacy at 90 days and Safety at 90 days. Started Sep 2012; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01525290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525290.